Purinone Derivative
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 6 of these applications claim priority to application PCT/JP2011/062377, filed May 30, 2011. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 8,557,803 | Purinone Derivative In force · High confidence | Ono Pharmaceutical Co., Ltd. | In force | High confidence | ||
| US 8,940,725 | Purinone Derivative In force · High confidence | Ono Pharmaceutical Co., Ltd. | In force | High confidence | ||
| US 9,879,013 | Purinone Derivative In force · High confidence | Ono Pharmaceutical Co., Ltd. | In force | High confidence | ||
| US 9,926,322 | Purinone Derivative In force · High confidence | Ono Pharmaceutical Co., Ltd. | In force | High confidence | ||
| US 10,233,185 | Purinone Derivative In force · Medium confidence | Ono Pharmaceutical Co., Ltd. | In force | Medium confidence | ||
| US 10,487,085 | Purinone Derivative In force · High confidence | Ono Pharmaceutical Co., Ltd. | In force | High confidence | ||
| Application 16/654,517 | Purinone Derivative Abandoned Abandoned Jan 12, 2022 | Ono Pharmaceutical Co., Ltd. | Abandoned | Abandoned Jan 12, 2022 | ||
| Application 17/570,934 | Purinone Derivative Abandoned Abandoned Aug 18, 2023 | Ono Pharmaceutical Co., Ltd. | Abandoned | Abandoned Aug 18, 2023 | ||
| Application 18/217,817 | Purinone Derivative Abandoned Abandoned Feb 11, 2025 | Ono Pharmaceutical Co., Ltd. | Abandoned | Abandoned Feb 11, 2025 | ||
| Application 18/931,806 | Purinone Derivative Pending Not granted | Ono Pharmaceutical Co., Ltd. | Pending | Not granted |
10 of 10 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
6 of these are in force and held by Ono Pharmaceutical Co., Ltd..
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.